Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells

Journal of Experimental Medicine

Volumn 212, Issue 7, 2015, Pages 1125-1137

  Odorizzi, Pamela M ^a   Pauken, Kristen E ^a   Paley, Michael A ^a   Sharpe, Arlene ^b,c,d   John Wherry, E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRAMMED DEATH 1 RECEPTOR; BROXURIDINE; PDCD1 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; GENE DELETION; LYMPHOCYTIC CHORIOMENINGITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; DEFICIENCY; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ADOPTIVE TRANSFER; ANIMALS; BROMODEOXYURIDINE; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; FLOW CYTOMETRY; LYMPHOCYTIC CHORIOMENINGITIS; MICE; PROGRAMMED CELL DEATH 1 RECEPTOR;

EID: 84948430497     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20142237     Document Type: Article

References (50)

1. Barber, D.L., E.J. Wherry, D. Masopust, B. Zhu, J.P. Allison, A.H. Sharpe, G.J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 439:682-687. http:// dx.doi.org/10.1038/nature04444
2. Blackburn, S.D., H. Shin, G.J. Freeman, and E.J. Wherry. 2008. Selective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockade. Proc. Natl. Acad. Sci. USA. 105:15016-15021. http://dx.doi.org/10.1073/ pnas.0801497105
3. + T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10:29-37. http://dx .doi.org/10.1038/ni.1679
4. + T cells. Cancer Res. 64:1140-1145. http://dx.doi.org/10.1158/0008-5472.CAN-03-3259
5. Blattman, J.N., E.J. Wherry, S.-J. Ha, R.G. van der Most, and R. Ahmed. 2009. Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infection. J. Virol. 83:4386-4394. http://dx .doi.org/10.1128/JVI.02524-08
6. Boni, C., P. Fisicaro, C. Valdatta, B. Amadei, P. Di Vincenzo, T. Giuberti, D. Laccabue, A. Zerbini, A. Cavalli, G. Missale, et al. 2007. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 81:4215-4225. http://dx.doi.org/10.1128/JVI .02844-06
7. Brahmer, J.R., S.S. Tykodi, L.Q.M. Chow, W.-J. Hwu, S.L. Topalian, P. Hwu, C.G. Drake, L.H. Camacho, J. Kauh, K. Odunsi, et al. 2012. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 366:2455-2465. http://dx.doi.org/10 .1056/NEJMoa1200694
8. Buggert, M., J. Tauriainen, T. Yamamoto, J. Frederiksen, M.A. Ivarsson, J. Michaëlsson, O. Lund, B. Hejdeman, M. Jansson, A. Sönnerborg, et al. 2014. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 10:e1004251. http://dx.doi.org/10.1371/journal.ppat.1004251
9. Butte, M.J., M.E. Keir, T.B. Phamduy, A.H. Sharpe, and G.J. Freeman. 2007. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity. 27:111- 122. http://dx.doi.org/10.1016/j.immuni.2007.05.016
10. Day, C.L., D.E. Kaufmann, P. Kiepiela, J.A. Brown, E.S. Moodley, S. Reddy, E.W. Mackey, J.D. Miller, A.J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 443:350-354. http://dx.doi .org/10.1038/nature05115
11. Frebel, H., V. Nindl, R.A. Schuepbach, T. Braunschweiler, K. Richter, J. Vogel, C.A. Wagner, D. Loffing-Cueni, M. Kurrer, B. Ludewig, and A. Oxenius. 2012. Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. J. Exp. Med. 209:2485- 2499. http://dx.doi.org/10.1084/jem.20121015
12. Gallimore, A., A. Glithero, A. Godkin, A.C. Tissot, A. Plückthun, T. Elliott, H. Hengartner, and R. Zinkernagel. 1998. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187:1383-1393. http://dx.doi .org/10.1084/jem.187.9.1383
13. Grupp, S.A., M. Kalos, D. Barrett, R. Aplenc, D.L. Porter, S.R. Rheingold, D.T. Teachey, A. Chew, B. Hauck, J.F. Wright, et al. 2013. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N. Engl. J. Med. 368:1509-1518. http://dx.doi.org/10.1056/NEJMoa1215134
14. Iwai, Y., S. Terawaki, and T. Honjo. 2005. PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells. Int. Immunol. 17:133-144. http://dx.doi .org/10.1093/intimm/dxh194
15. James, E.S., S. Harney, B.P. Wordsworth, W.O.C.M. Cookson, S.J. Davis, and M.F. Moffatt. 2005. PDCD1: a tissue-specific susceptibility locus for inherited inflammatory disorders. Genes Immun. 6:430-437. http:// dx.doi.org/10.1038/sj.gene.6364223
16. + T cell responses during chronic infection. Nat. Immunol. 12:663-671. http://dx.doi.org/10 .1038/ni.2046
17. + T cell function by multiple costimulatory receptors during chronic HIV infection. J. Immunol. 185:3007- 3018. http://dx.doi.org/10.4049/jimmunol.1000156
18. + T cell responses to antigen in lymph nodes and tissues. J. Immunol. 179:5064-5070. http://dx.doi.org/10.4049/jimmunol.179.8 .5064
19. Keir, M.E., M.J. Butte, G.J. Freeman, and A.H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26:677-704. http://dx.doi.org/10.1146/annurev.immunol.26.021607.090331
20. + T cells. Immunity. 42:265-278. http://dx.doi.org/10.1016/j.immuni .2015.01.006
21. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056-8063.
22. McCune, J.M., M.B. Hanley, D. Cesar, R. Halvorsen, R. Hoh, D. Schmidt, E. Wieder, S. Deeks, S. Siler, R. Neese, and M. Hellerstein. 2000. Factors influencing T-cell turnover in HIV-1-seropositive patients. J. Clin. Invest. 105:R1-R8. http://dx.doi.org/10.1172/JCI8647
23. Muenst, S., S. Hoeller, N. Willi, S. Dirnhofera, and A. Tzankov. 2010. Diagnostic and prognostic utility of PD-1 in B cell lymphomas. Dis. Markers. 29:47-53. http://dx.doi.org/10.1155/2010/404069
24. Muenst, S., S.D. Soysal, F. Gao, E.C. Obermann, D. Oertli, and W.E. Gillanders. 2013. The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer. Breast Cancer Res. Treat. 139:667-676. http://dx .doi.org/10.1007/s10549-013-2581-3
25. Okazaki, T., A. Maeda, H. Nishimura, T. Kurosaki, and T. Honjo. 2001. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc. Natl. Acad. Sci. USA. 98:13866-13871. http:// dx.doi.org/10.1073/pnas.231486598
26. Paley, M.A., D.C. Kroy, P.M. Odorizzi, J.B. Johnnidis, D.V. Dolfi, B.E. Barnett, E.K. Bikoff, E.J. Robertson, G.M. Lauer, S.L. Reiner, and E.J. Wherry. 2012. Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science. 338:1220-1225. http://dx.doi.org/10.1126/science.1229620
27. Pardoll, D.M. 2012. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer. 12:252-264. http://dx.doi.org/10 .1038/nrc3239
28. Parry, R.V., J.M. Chemnitz, K.A. Frauwirth, A.R. Lanfranco, I. Braunstein, S.V. Kobayashi, P.S. Linsley, C.B. Thompson, and J.L. Riley. 2005. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell. Biol. 25:9543-9553. http://dx.doi.org/10.1128/ MCB.25.21.9543-9553.2005
29. Patsoukis, N., J. Brown, V. Petkova, F. Liu, L. Li, and V.A. Boussiotis. 2012. Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation. Sci. Signal. 5:ra46. http://dx.doi.org/10.1126/scisignal.2002796
30. + T cell survival in HIV infection. J. Exp. Med. 203:2281-2292. http://dx.doi .org/10.1084/jem.20061496
31. Pircher, H., K. Bürki, R. Lang, H. Hengartner, and R.M. Zinkernagel. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature. 342:559-561. http://dx.doi.org/10 .1038/342559a0
32. Restifo, N.P., M.E. Dudley, and S.A. Rosenberg. 2012. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat. Rev. Immunol. 12:269-281. http://dx.doi.org/10.1038/nri3191
33. Riley, J.L. 2009. PD-1 signaling in primary T cells. Immunol. Rev. 229:114- 125. http://dx.doi.org/10.1111/j.1600-065X.2009.00767.x
34. Sakuishi, K., L. Apetoh, J.M. Sullivan, B.R. Blazar, V.K. Kuchroo, and A.C. Anderson. 2010. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J. Exp. Med. 207:2187-2194. http://dx.doi.org/10.1084/jem.20100643
35. Shin, H., S.D. Blackburn, J.N. Blattman, and E.J. Wherry. 2007. Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection. J. Exp. Med. 204:941-949. http://dx.doi.org/10 .1084/jem.20061937
36. + T cell exhaustion during chronic viral infection. Immunity. 31:309-320. http://dx.doi.org/10.1016/j.immuni.2009.06.019
37. + T cells during chronic infection. Immunity. 41:802-814. http://dx.doi.org/10.1016/j.immuni.2014.10.013
38. Topalian, S.L., F.S. Hodi, J.R. Brahmer, S.N. Gettinger, D.C. Smith, D.F. McDermott, J.D. Powderly, R.D. Carvajal, J.A. Sosman, M.B. Atkins, et al. 2012. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366:2443-2454. http://dx.doi.org/ 10.1056/NEJMoa1200690
39. Urbani, S., B. Amadei, D. Tola, M. Massari, S. Schivazappa, G. Missale, and C. Ferrari. 2006. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J. Virol. 80:11398-11403. http://dx.doi.org/10.1128/JVI.01177-06
40. Velázquez-Cruz, R., L. Orozco, F. Espinosa-Rosales, R. Carreño-Manjarrez, E. Solís-Vallejo, N.D. López-Lara, I.K. Ruiz-López, A.L. Rodríguez- Lozano, J.K. Estrada-Gil, G. Jiménez-Sánchez, and V. Baca. 2007. Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus. Eur. J. Hum. Genet. 15:336-341. http://dx.doi .org/10.1038/sj.ejhg.5201767
41. Velu, V., K. Titanji, B. Zhu, S. Husain, A. Pladevega, L. Lai, T.H. Vanderford, L. Chennareddi, G. Silvestri, G.J. Freeman, et al. 2009. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature. 458:206-210. http://dx.doi.org/10.1038/nature07662
42. Virgin, H.W., E.J. Wherry, and R. Ahmed. 2009. Redefining chronic viral infection. Cell. 138:30-50. http://dx.doi.org/10.1016/j.cell.2009.06.036
43. Wherry, E.J. 2011. T cell exhaustion. Nat. Immunol. 12:492-499. http:// dx.doi.org/10.1038/ni.2035
44. Wherry, E.J., J.N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003a. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77:4911-4927. http://dx.doi.org/10.1128/JVI.77 .8.4911-4927.2003
45. Wherry, E.J., V. Teichgräber, T.C. Becker, D. Masopust, S.M. Kaech, R. Antia, U.H. von Andrian, and R. Ahmed. 2003b. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4:225-234. http://dx.doi.org/10.1038/ni889
46. Wherry, E.J., S.J. Ha, S.M. Kaech, W.N. Haining, S. Sarkar, V. Kalia, S. Subramaniam, J.N. Blattman, D.L. Barber, and R. Ahmed. 2007. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity. 27:670-684. http://dx.doi.org/10.1016/j.immuni .2007.09.006
47. Yokosuka, T., M. Takamatsu, W. Kobayashi-Imanishi, A. Hashimoto- Tane, M. Azuma, and T. Saito. 2012. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J. Exp. Med. 209:1201-1217. http://dx.doi.org/10.1084/jem.20112741
48. Zajac, A.J., J.N. Blattman, K. Murali-Krishna, D.J. Sourdive, M. Suresh, J.D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-2213. http://dx.doi.org/10.1084/jem.188.12.2205
49. Zhang, G., Q. Han, S. Duan, Z. Li, N. Li, Q. Zhu, J. Chen, Y. Lv, X. Zeng, Y. Chen, and Z. Liu. 2012. PDCD1 polymorphism amplifies the predisposing effect conferred by CTLA4 polymorphism in chronic hepatitis B virus infection. Hum. Immunol. 73:421-425. http://dx.doi .org/10.1016/j.humimm.2012.01.013
50. Zinselmeyer, B.H., S. Heydari, C. Sacristán, D. Nayak, M. Cammer, J. Herz, X. Cheng, S.J. Davis, M.L. Dustin, and D.B. McGavern. 2013. PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis. J. Exp. Med. 210:757-774. http://dx.doi.org/10.1084/jem.20121416